Aquestive Therapeutics: Q2 Earnings Insights


Aquestive Therapeutics AQST reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.


Aquestive Therapeutics reported in-line EPS of $-0.36 versus an estimate of $-0.36.

Revenue was down $2.08 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.09 which was followed by a 3.65% increase in the share price the next day.

Here's a look at Aquestive Therapeutics's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.41 -0.47 -0.45 -0.44
EPS Actual -0.32 -0.38 -0.37 -0.33
Revenue Estimate 10.11M 9.36M 11.01M 9.48M
Revenue Actual 12.27M 11.08M 13.29M 15.35M

To track all earnings releases for Aquestive Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps